T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Medifast
MED
$130M
| $1.95M | ﹤0.01% |
9,218
-1,308
| -12% | -$313K |
|
1727
BOK Financial
BOKF
$8.85B
| $1.95M | ﹤0.01% |
21,832
-292,753
| -93% | -$24.8M |
|
1728
Park National Corp
PRK
$3.75B
| $1.94M | ﹤0.01% |
15,009
-2,649
| -15% | -$322K |
|
1729
Varonis Systems
VRNS
$5.26B
| $1.94M | ﹤0.01% |
37,802
-2,668
| -7% | -$158K |
|
1730
OneMain Financial
OMF
$7.44B
| $1.94M | ﹤0.01% |
36,090
+2,291
| +7% | +$118K |
|
1731
RLJ Lodging Trust
RLJ
$1.67B
| $1.94M | ﹤0.01% |
125,171
+420
| +0.3% | +$6.28K |
|
|
LSXMA
1732
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $1.94M | ﹤0.01% |
59,737
+1,626
| +3% | +$52.1K |
|
1733
Adient
ADNT
$1.44B
| $1.93M | ﹤0.01% |
43,682
-688
| -2% | -$26K |
|
|
SAIL
1734
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $1.93M | ﹤0.01% |
38,013
+2,795
| +8% | +$157K |
|
1735
Simmons First National
SFNC
$3.45B
| $1.92M | ﹤0.01% |
64,680
+1,598
| +3% | +$44.9K |
|
1736
Neogen
NEOG
$2.59B
| $1.92M | ﹤0.01% |
43,152
-5,482
| -11% | -$230K |
|
1737
Pediatrix Medical
MD
$2.15B
| $1.92M | ﹤0.01% |
75,238
-2,509
| -3% | -$64.3K |
|
1738
Donnelley Financial Solutions
DFIN
$1.17B
| $1.9M | ﹤0.01% |
68,117
-17,373
| -20% | -$402K |
|
1739
Wingstop
WING
$3.1B
| $1.9M | ﹤0.01% |
14,905
+806
| +6% | +$113K |
|
1740
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $1.89M | ﹤0.01% |
4,775
-311
| -6% | -$120K |
|
|
FRBK
1741
DELISTED
Republic First Bancorp Inc
FRBK
| $1.89M | ﹤0.01% |
+502,145
| New | +$1.72M |
|
|
JHG
1742
DELISTED
Janus Henderson
JHG
| $1.89M | ﹤0.01% |
60,713
+7,800
| +15% | +$245K |
|
1743
Bank OZK
OZK
$5.69B
| $1.89M | ﹤0.01% |
46,217
-1,242
| -3% | -$48.9K |
|
1744
Virgin Galactic
SPCE
$475M
| $1.89M | ﹤0.01% |
3,078
+50
| +2% | +$37.6K |
|
1745
Vontier
VNT
$4.52B
| $1.88M | ﹤0.01% |
62,225
-179,871
| -74% | -$5.87M |
|
1746
H&R Block
HRB
$6.76B
| $1.88M | ﹤0.01% |
86,340
+17,223
| +25% | +$326K |
|
|
MNDT
1747
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $1.87M | ﹤0.01% |
95,664
+17,583
| +23% | +$367K |
|
1748
Morningstar
MORN
$7.41B
| $1.87M | ﹤0.01% |
8,310
+2,736
| +49% | +$641K |
|
1749
Vishay Intertechnology
VSH
$5.11B
| $1.86M | ﹤0.01% |
77,431
-3,637
| -4% | -$85.1K |
|
1750
Antero Midstream
AM
$10.5B
| $1.86M | ﹤0.01% |
206,344
+56,051
| +37% | +$483K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.